Consortium Members
The TOpClass consortium is an international collaboration that brings together world-class experts to advance understanding and management of perianal Crohn’s disease. Our research explores disease pathogenesis, classification of phenotypes, and how healing and outcomes can be measured more reliably across centres.
Bridging surgery, gastroenterology, radiology and translational science, we have developed practical, evidence-based tools that enhance patient care and bring greater consistency to research worldwide.
University of Chicago Medical Center, Chicago, U.S.A
City: Chicago | Country: USA
Consortium description coming soon
University of British Columbia, Vancouver, Canada
City: Vancouver | Country: Canada
Astrid Williams has joined the team at the IBD centre of B in 2024. From 2018 to 2023, she was a Staff Specialist Gastroenterologist at Liverpool Hospital in Sydney, Australia.
Icahn School of Medicine at Mount Sinai
City: New York | Country: America
The perianal fistulizing Crohn’s disease clinical and research program at The Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center at Mount Sinai is co-led by gastroenterologist Dr. Serre-Yu Wong and colorectal surgeon Dr Sergey Khaitov.
Washington University School of Medicine in St. Louis
City: Washington I Country: America
The Fistula Research Unit at St. Mark’s Hospital is headed by Professor Ailsa Hart and Mr Phil Tozer. The centre has a strong history of championing research in the field of perianal Crohn’s Disease and progressing the medical and surgical management of perianal fistula.
Lightner Lab at Calibr Skaggs in San Diego, US
City: San Diego | Country: United States
Led by Dr. Amy Lightner, a colorectal surgeon and Professor of Molecular and Cellular Biology and Professor of Immunology, the Lightner Lab at Scripps Research is dedicated to pioneering research in inflammatory bowel disease (IBD) and advancing novel treatment strategies for both complex luminal disease and perianal fistulizing disease…